Hofheim, Germany

Harry Schwartz

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry Schwartz. Retrieved from https://idiyas.com/inventor/harry-schwartz-1bjpxd9b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harry Schwartz

Introduction

Harry Schwartz is a notable inventor based in Hofheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sulfamidothienopyrimidines. His dedication to research and development has led to the creation of valuable compounds that have potential applications in medicine.

Latest Patents

Harry Schwartz holds one patent for his invention related to sulfamidothienopyrimidines. This patent involves compounds of the formula (I), where R, E, and X are defined in the patent documentation. His work in this area showcases his expertise and commitment to advancing pharmaceutical science.

Career Highlights

Schwartz is currently employed at Merck Patent GmbH, a leading company in the pharmaceutical industry. His role at Merck has allowed him to engage in cutting-edge research and contribute to the development of new therapeutic solutions. His work is characterized by a focus on innovation and the practical application of scientific discoveries.

Collaborations

Throughout his career, Harry has collaborated with esteemed colleagues such as Hans-Michael Eggenweiler and Pierre Schelling. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research efforts.

Conclusion

In summary, Harry Schwartz is a distinguished inventor whose work on sulfamidothienopyrimidines has made a significant impact in the pharmaceutical field. His contributions, along with his collaborations at Merck Patent GmbH, highlight the importance of innovation in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…